EdgarLookup

Tonix Pharmaceuticals Holding Corp. — 8-K Filings

671 8-K filings on record

This page lists all 8-K filings submitted to the SEC by Tonix Pharmaceuticals Holding Corp. (TNXP), sorted by most recent first. Each row links to the full filing on EdgarLookup. Tonix Pharmaceuticals Holding Corp. has filed 671 8-K documents with the SEC since 2016. To view all SEC filings by Tonix Pharmaceuticals Holding Corp., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-Q 3 4 4/A 424B3 424B4 424B5 5 8-A12B 8-A12G 8-K 8-K/A ARS AW CERTNAS CORRESP CT ORDER D D/A DEF 14A DEFA14A EFFECT FWP NT 10-K NT 10-Q POS AM POS EX PRE 14A RW S-1 S-1/A S-3 S-3/A S-3MEF S-8 SC 13D SC 13D/A SC 13G SC 13G/A SC 14F1 SCHEDULE 13G SCHEDULE 13G/A SEC STAFF LETTER UPLOAD
Form Description Accession Number Filed Period
8-K CURRENT REPORT 0001999371-25-001243 Feb 6, 2025
8-K CURRENT REPORT 0001999371-25-001136 Feb 4, 2025 Feb 3, 2025
8-K CURRENT REPORT 0001999371-25-001105 Feb 3, 2025
8-K CURRENT REPORT 0001999371-25-000195 Jan 8, 2025
8-K CURRENT REPORT 0001999371-24-015671 Dec 23, 2024
8-K CURRENT REPORT 0001839882-24-046555 Dec 20, 2024
8-K CURRENT REPORT 0001999371-24-015450 Dec 17, 2024
8-K CURRENT REPORT 0001839882-24-043099 Dec 3, 2024
8-K CURRENT REPORT 0001999371-24-014604 Nov 13, 2024
8-K CURRENT REPORT 0001999371-24-014466 Nov 12, 2024
8-K CURRENT REPORT 0001839882-24-038453 Nov 8, 2024
8-K CURRENT REPORT 0001839882-24-037168 Nov 4, 2024
8-K CURRENT REPORT 0001839882-24-036731 Nov 1, 2024
8-K CURRENT REPORT 0001999371-24-014188 Oct 30, 2024
8-K CURRENT REPORT 0001999371-24-014008 Oct 28, 2024
8-K CURRENT REPORT 0001839882-24-034021 Oct 17, 2024
8-K CURRENT REPORT 0001839882-24-033909 Oct 16, 2024
8-K CURRENT REPORT 0001839882-24-032980 Oct 8, 2024
8-K CURRENT REPORT 0001839882-24-031012 Sep 27, 2024
8-K CURRENT REPORT 0001839882-24-030149 Sep 23, 2024
8-K CURRENT REPORT 0001839882-24-029804 Sep 19, 2024
8-K CURRENT REPORT 0001839882-24-029343 Sep 16, 2024
8-K CURRENT REPORT 0001839882-24-028820 Sep 10, 2024
8-K CURRENT REPORT 0001839882-24-028650 Sep 9, 2024 Sep 6, 2024
8-K CURRENT REPORT 0001999371-24-011581 Sep 6, 2024
8-K CURRENT REPORT 0001999371-24-011157 Aug 30, 2024
8-K CURRENT REPORT 0001839882-24-027198 Aug 29, 2024
8-K CURRENT REPORT 0001839882-24-026712 Aug 26, 2024
8-K CURRENT REPORT 0001839882-24-026274 Aug 20, 2024
8-K CURRENT REPORT 0001839882-24-026135 Aug 19, 2024
8-K CURRENT REPORT 0001999371-24-009889 Aug 12, 2024
8-K CURRENT REPORT 0001999371-24-009864 Aug 9, 2024
8-K CURRENT REPORT 0001999371-24-009272 Jul 30, 2024
8-K CURRENT REPORT 0001999371-24-009017 Jul 25, 2024
8-K CURRENT REPORT 0001839882-24-021878 Jul 16, 2024
8-K CURRENT REPORT 0001999371-24-008473 Jul 10, 2024 Jul 8, 2024
8-K CURRENT REPORT 0001839882-24-021193 Jul 8, 2024
8-K CURRENT REPORT 0001839882-24-020329 Jul 1, 2024 Jun 28, 2024
8-K CURRENT REPORT 0001999371-24-008001 Jun 28, 2024 Jun 26, 2024
8-K CURRENT REPORT 0001999371-24-007804 Jun 26, 2024
8-K CURRENT REPORT 0001839882-24-019198 Jun 20, 2024
8-K CURRENT REPORT 0001999371-24-007447 Jun 13, 2024 Jun 11, 2024
8-K CURRENT REPORT 0001839882-24-018368 Jun 10, 2024
8-K CURRENT REPORT 0001999371-24-007198 Jun 6, 2024
8-K CURRENT REPORT 0001839882-24-018059 Jun 6, 2024
8-K CURRENT REPORT 0001839882-24-017297 Jun 3, 2024
8-K CURRENT REPORT 0001839882-24-016704 May 30, 2024
8-K CURRENT REPORT 0001839882-24-016019 May 22, 2024
8-K CURRENT REPORT 0001999371-24-006472 May 22, 2024 May 21, 2024
8-K CURRENT REPORT 0001999371-24-006367 May 21, 2024